Skip to main content

Advertisement

SpringerLink
Log in

Rubbing Salt into Wounds: Hypertonic Saline to Assist with Volume Removal in Heart Failure

  • Published:
Current Heart Failure Reports Aims and scope Submit manuscript

Abstract

Traditionally accepted management strategies for patients with heart failure include sodium and fluid restriction, neurohormonal blockade, and the use of loop diuretics to achieve and maintain euvolemia. Despite continued advances in medical and device therapy, fluid management remains a significant problem in patients with the cardiorenal syndrome (manifested as diuretic resistance and worsening renal function with more aggressive attempts at volume removal). This article examines the counterintuitive use of hypertonic saline as a potential therapy to facilitate diuresis in patients with decompensated heart failure and diuretic resistance. Low-volume hypertonic saline administration offsets counterproductive neurohormonal upregulation, transiently improves hemodynamics, and promotes renal sodium excretion with accompanied net water loss and preservation of renal function. This “new” therapeutic tool should be explored further as an adjunct to current medical therapies in the management of patients with refractory volume overload.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Forman DE, Butler J, Wang Y, et al.: Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 2004, 43:61–67.

    Article  PubMed  Google Scholar 

  2. Cowie MR, Komajda M, Murray-Thomas T, et al.: Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH). Eur Heart J 2006, 27:1216–1222.

    Article  PubMed  Google Scholar 

  3. Klein L, Massie BM, Leimberger JD, et al.: Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF). Circ Heart Fail 2008, 1:25–33.

    Article  CAS  PubMed  Google Scholar 

  4. Sackner-Bernstein JD, Skopicki HA, Aaronson KD: Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 2005, 111:1487–1491. (Published erratum appears in Circulation 2005, 111:2274.)

    Article  CAS  PubMed  Google Scholar 

  5. Costanzo MR, Guglin ME, Saltzberg MT, et al.: Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 2007, 49:675–683. (Published erratum appears in J Am Coll Cardiol 2007, 49:1136.)

    Article  CAS  PubMed  Google Scholar 

  6. Konstam MA, Gheorghiade M, Burnett JC Jr, et al.: Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA 2007, 297:1319–1331.

    Article  CAS  PubMed  Google Scholar 

  7. Voors A: Effects of the adenosine A1-antagonist rolofylline on renal function in acute heart failure patients: results from the PROTECT study. J Am Coll Cardiol 2010, 55:E317.

    Article  Google Scholar 

  8. Cadnapaphornchai MA, Gurevich AK, Weinberger HD, Schrier RW: Pathophysiology of sodium and water retention in heart failure. Cardiology 2001, 96:122–131.

    Article  CAS  PubMed  Google Scholar 

  9. Bell-Reuss E, Trevino DL, Gottschalk CW: Effect of renal sympathetic nerve stimulation on proximal water and sodium reabsorption. J Clin Invest 1976, 57:1104–1107.

    Article  CAS  PubMed  Google Scholar 

  10. Blankstein R, Bakris GL: Renal hemodynamic changes in heart failure. Heart Fail Clin 2008, 4:411–423.

    Article  PubMed  Google Scholar 

  11. Jessup M, Costanzo MR: The cardiorenal syndrome: do we need a change of strategy or a change of tactics? J Am Coll Cardiol 2009, 53:597–599.

    Article  PubMed  Google Scholar 

  12. Kastner PR, Hall JE, Guyton AC: Renal hemodynamic responses to increased renal venous pressure: role of angiotensin II. Am J Physiol 1982, 243:F260–F264.

    CAS  PubMed  Google Scholar 

  13. Bayliss J, Norell M, Canepa-Anson R, et al.: Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. Br Heart J 1987, 57:17–22.

    Article  CAS  PubMed  Google Scholar 

  14. Ellison DH: Diuretic therapy and resistance in congestive heart failure. Cardiology 2001, 96:132–143.

    Article  CAS  PubMed  Google Scholar 

  15. Vandongen R: Intrarenal stimulation of renin secretion by frusemide in the isolated kidney of the rat. Br J Pharmacol 1977, 60:73–76.

    CAS  PubMed  Google Scholar 

  16. Kaissling B, Bachmann S, Kriz W: Structural adaptation of the distal convoluted tubule to prolonged furosemide treatment. Am J Physiol 1985, 248:F374–F381.

    CAS  PubMed  Google Scholar 

  17. Ellison DH, Velázquez H, Wright FS: Adaptation of the distal convoluted tubule of the rat. Structural and functional effects of dietary salt intake and chronic diuretic infusion. J Clin Invest 1989, 83:113–126.

    Article  CAS  PubMed  Google Scholar 

  18. Alvelos M, Ferreira A, Bettencourt P, et al.: The effect of dietary sodium restriction on neurohumoral activity and renal dopaminergic response in patients with heart failure. Eur J Heart Fail 2004, 6:593–599.

    CAS  PubMed  Google Scholar 

  19. Ronco C, Haapio M, House AA, et al.: Cardiorenal syndrome. J Am Coll Cardiol 2008, 52:1527–1539.

    Article  PubMed  Google Scholar 

  20. Paterna S, Di Pasquale P, Parrinello G, et al.: Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure. Eur J Heart Fail 2000, 2:305–313.

    Article  CAS  PubMed  Google Scholar 

  21. •• Paterna S, Di Pasquale P, Parrinello G, et al.: Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study. J Am Coll Cardiol 2005, 45:1997–2003. This article represents a double-blind randomized trial comparing the effects of small volumes of hypertonic saline plus high-dose diuretic therapy and a liberal dietary sodium intake to high-dose diuretic therapy alone with a restricted dietary sodium intake in patients with decompensated heart failure and diuretic resistance. This article also compares the effects of these two treatment strategies on B-type natriuretic peptide levels and on total body water content as measured by thoracic impedance.

    Article  CAS  PubMed  Google Scholar 

  22. • Paterna S, Fasullo S, Di Pasquale P: High-dose torasemide is equivalent to high-dose furosemide with hypertonic saline in the treatment of refractory congestive heart failure. Clin Drug Investig 2005, 25:165–173. This article compares the efficacy of small volumes of hypertonic saline in addition to furosemide versus torsemide in patients with decompensated heart failure and diuretic resistance.

    Article  CAS  PubMed  Google Scholar 

  23. Licata G, Di Pasquale P, Parrinello G, et al.: Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects. Am Heart J 2003, 145:459–466.

    Article  CAS  PubMed  Google Scholar 

  24. Hunt SA, Abraham WT, Chin MH, et al.: 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 2009, 53:e1–e90. (Published erratum appears in J Am Coll Cardiol 2009, 54:2464.)

    Article  PubMed  Google Scholar 

  25. Damgaard M, Gabrielsen A, Heer M, et al.: Effects of sodium intake on cardiovascular variables in humans during posture changes and ambulatory conditions. Am J Physiol Regul Integr Comp Physiol 2002, 283:R1404–R1411.

    CAS  PubMed  Google Scholar 

  26. Damgaard M, Norsk P, Gustafsson F, et al.: Hemodynamic and neuroendocrine responses to changes in sodium intake in compensated heart failure. Am J Physiol Regul Integr Comp Physiol 2006, 290:R1294–R1301.

    CAS  PubMed  Google Scholar 

  27. Paterna S, Gaspare P, Fasullo S, et al.: Normal-sodium diet compared with low-sodium diet in compensated congestive heart failure: is sodium an old enemy or a new friend? Clin Sci (Lond) 2008, 114:221–230.

    Article  CAS  Google Scholar 

  28. Oliveira RP, Velasco I, Soriano F, Friedman G: Clinical review: Hypertonic saline resuscitation in sepsis. Crit Care 2002, 6:418–423.

    Article  PubMed  Google Scholar 

  29. Tølløfsrud S, Noddeland H: Hypertonic saline and dextran after coronary artery surgery mobilises fluid excess and improves cardiorespiratory functions. Acta Anaesthesiol Scand 1998, 42:154–161.

    Article  PubMed  Google Scholar 

  30. Tølløfsrud S, Mathru M, Kramer GC: Hypertonic–hyperoncotic solutions in open-heart surgery. Perfusion 1998, 13:289–296.

    PubMed  Google Scholar 

  31. Wildenthal K, Mierzwiak DS, Mitchell JH: Acute effects of increased serum osmolality on left ventricular performance. Am J Physiol 1969, 216:898–904.

    CAS  PubMed  Google Scholar 

  32. Schroth M, Plank C, Meissner U, et al.: Hypertonic–hyperoncotic solutions improve cardiac function in children after open-heart surgery. Pediatrics 2006, 118:e76–e84.

    Article  PubMed  Google Scholar 

  33. Bueno R, Resende AC, Melo R, et al.: Effects of hypertonic saline-dextran solution in cardiac valve surgery with cardiopulmonary bypass. Ann Thorac Surg 2004, 77:604–611.

    Article  PubMed  Google Scholar 

  34. Mouren S, Delayance S, Mion G, et al.: Mechanisms of increased myocardial contractility with hypertonic saline solutions in isolated blood-perfused rabbit hearts. Anesth Analg 1995, 81:777–782.

    Article  CAS  PubMed  Google Scholar 

  35. Fujita T, Matsuda Y, Shibamoto T, et al.: Effect of hypertonic saline infusion on renal vascular resistance in anesthetized dogs. Jpn J Physiol 1991, 41:653–663.

    Article  CAS  PubMed  Google Scholar 

  36. Gerber JG, Branch RA, Nies AS, et al.: Influence of hypertonic saline on canine renal blood flow and renin release. Am J Physiol 1979, 237:F441–F446.

    CAS  PubMed  Google Scholar 

  37. Tucker BJ, Blantz RC: Effect of furosemide administration on glomerular and tubular dynamics in the rat. Kidney Int 1984, 26:112–121.

    Article  CAS  PubMed  Google Scholar 

  38. He XR, Greenberg SG, Briggs JP, Schnermann J: Effects of furosemide and verapamil on the NaCl dependency of macula densa-mediated renin secretion. Hypertension 1995, 26:137–142.

    CAS  PubMed  Google Scholar 

  39. Clinical Trials.gov: Safety and efficacy of low dose hypertonic saline solution and high dose furosemide for congestive heart failure (REaCH). Available at http://www.clinicaltrials.gov/ct2/show/NCT01028170. Accessed June 2010.

  40. Clinical Trials.gov: Hypertonic saline solution in heart failure. Available at http://www.clinicaltrials.gov/ct2/show/NCT00555685. Accessed June 2010.

  41. Tuttolomondo A, Pinto A, Di Raimondo D, et al.: Changes in natriuretic peptide and cytokine plasma levels in patients with heart failure, after treatment with high dose of furosemide plus hypertonic saline solution (HSS) and after a saline loading. Nutr Metab Cardiovasc Dis 2010 Mar 24 (Epub ahead of print).

  42. Parrinello G, Di Pasquale P, Licata G, et al.: Long-term effects of dietary sodium intake on cytokines and neurohormonal activation in patients with recently compensated congestive heart failure. J Card Fail 2009, 15:864–873.

    Article  CAS  PubMed  Google Scholar 

  43. Miettinen KH, Lassus J, Harjola VP, et al.: Prognostic role of pro- and anti-inflammatory cytokines and their polymorphisms in acute decompensated heart failure. Eur J Heart Fail 2008, 10:396–403.

    Article  CAS  PubMed  Google Scholar 

Download references

Disclosures

No potential conflicts of interest relevant to this article have been reported.

Author information

Authors and Affiliations

  1. Brigham and Women’s Hospital, 75 Francis Street, Boston, MA, 02115, USA

    Mark Liszkowski & Anju Nohria

Authors
  1. Mark Liszkowski
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anju Nohria
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anju Nohria.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liszkowski, M., Nohria, A. Rubbing Salt into Wounds: Hypertonic Saline to Assist with Volume Removal in Heart Failure. Curr Heart Fail Rep 7, 134–139 (2010). https://doi.org/10.1007/s11897-010-0018-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11897-010-0018-4

Keywords

Search

Navigation